MYCN and neuroblastoma: Of the five stage 3 neuroblastomas in our prior series [5], microvessel integrin αvβ3 expression was high in the three MYCN-amplified tumors (mean 87% of microvessels, 95% CI 79%–94%), but low in the two MYCN-non-amplified ones (mean 20% of microvessels).